CUE BIOPHARMA INC (CUE)

US22978P1066 - Common Stock

1.07  -0.02 (-1.83%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
9.53M5.49M1.25M14.94M3.15M
Operating Expenses
55.17M57.48M54.75M58.65M48.20M
Research and Development
40.00M40.28M37.76M40.19M32.59M
Selling, General, and Administrative Expenses
15.17M16.66M16.15M17.29M14.55M
Operating Income
-45.64M-51.99M-53.50M-43.71M-45.04M
Interest Income/Expense
1.09M1.42M210.00K20.00K460.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/A-157.00K280.00KN/AN/A
Income Before Taxes
-44.61M-50.73M-53.01M-43.67M-44.58M
Income Tax
N/AN/A0.00500.00K210.00K
Net Income
-44.61M-50.73M-53.01M-44.16M-44.78M
EBITDA
-45.22M-51.44M-52.58M-42.45M-43.98M
 
Per Share Data
EPS Diluted Total Ops
-0.91-1.11-1.49-1.41-1.56
Non GAAP EPS
-0.91-1.11-1.50-1.40-1.56
 
Statistics
Profit Margin
-468.02%-924.10%-4240.80%-295.58%-1421.59%
Operating Profit Margin
-478.79%-947.03%-4280.00%-292.57%-1429.84%

All data in USD

Charts